JP2025513879A5 - - Google Patents
Info
- Publication number
- JP2025513879A5 JP2025513879A5 JP2024560636A JP2024560636A JP2025513879A5 JP 2025513879 A5 JP2025513879 A5 JP 2025513879A5 JP 2024560636 A JP2024560636 A JP 2024560636A JP 2024560636 A JP2024560636 A JP 2024560636A JP 2025513879 A5 JP2025513879 A5 JP 2025513879A5
- Authority
- JP
- Japan
- Prior art keywords
- ice
- cell
- cell according
- sequence
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263330539P | 2022-04-13 | 2022-04-13 | |
| US63/330,539 | 2022-04-13 | ||
| US202363448081P | 2023-02-24 | 2023-02-24 | |
| US63/448,081 | 2023-02-24 | ||
| PCT/US2023/018189 WO2023200796A1 (en) | 2022-04-13 | 2023-04-11 | Immune cell inhibition by immune checkpoint engagers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025513879A JP2025513879A (ja) | 2025-04-30 |
| JP2025513879A5 true JP2025513879A5 (https=) | 2026-04-15 |
Family
ID=88330149
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024560636A Pending JP2025513879A (ja) | 2022-04-13 | 2023-04-11 | 免疫チェックポイントエンゲージャーによる免疫細胞の抑制 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20250268949A1 (https=) |
| EP (1) | EP4507727A4 (https=) |
| JP (1) | JP2025513879A (https=) |
| CN (1) | CN119183385A (https=) |
| AU (1) | AU2023251864A1 (https=) |
| CA (1) | CA3247422A1 (https=) |
| WO (1) | WO2023200796A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2024177982A2 (en) * | 2023-02-24 | 2024-08-29 | The Regents Of The University Of California | Lilrb1 engager cells |
| WO2025098508A1 (zh) * | 2023-11-10 | 2025-05-15 | 贝达药业股份有限公司 | 标记性多肽、治疗剂及其应用 |
| WO2025166550A1 (zh) * | 2024-02-06 | 2025-08-14 | 香港北恒生物科技有限公司 | 工程化细胞及其用途 |
| CN117903311B (zh) * | 2024-03-20 | 2024-10-25 | 湖南卓润生物科技有限公司 | sST2特异性结合蛋白及其制备方法和应用 |
| CN120340611B (zh) * | 2025-04-02 | 2025-09-23 | 中瑞德泰生物科技集团有限公司 | Car-nk细胞数据的特征提取方法及系统 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2488876A1 (en) * | 2002-06-13 | 2003-12-24 | Oregon Health & Science University | Activating mutations of platelet derived growth factor receptor alpha (pdgfra) as diagnostic markers and therapeutic targets |
| US20180133327A1 (en) * | 2015-03-16 | 2018-05-17 | Amal Therapeutics Sa | Cell Penetrating Peptides and Complexes Comprising the Same |
| JP2020506943A (ja) * | 2017-02-07 | 2020-03-05 | メモリアル スローン ケタリング キャンサー センター | 養子免疫療法における抗原特異的ｔ細胞と組み合わせた免疫チェックポイント調節剤の使用 |
| KR102777151B1 (ko) * | 2017-11-21 | 2025-03-05 | 더 보드 어브 트러스티스 어브 더 리랜드 스탠포드 주니어 유니버시티 | 인터루킨-2의 부분 효능제 |
| AR114127A1 (es) * | 2018-03-02 | 2020-07-22 | Lilly Co Eli | Anticuerpos agonistas contra pd-1 y usos de estos |
| US11840575B2 (en) * | 2019-05-07 | 2023-12-12 | Gracell Biotechnologies (Shanghai) Co., Ltd. | Engineered immune cells targeting BCMA and their uses thereof |
-
2023
- 2023-04-11 CA CA3247422A patent/CA3247422A1/en active Pending
- 2023-04-11 JP JP2024560636A patent/JP2025513879A/ja active Pending
- 2023-04-11 EP EP23788856.5A patent/EP4507727A4/en active Pending
- 2023-04-11 CN CN202380040146.6A patent/CN119183385A/zh active Pending
- 2023-04-11 US US18/853,080 patent/US20250268949A1/en active Pending
- 2023-04-11 AU AU2023251864A patent/AU2023251864A1/en active Pending
- 2023-04-11 WO PCT/US2023/018189 patent/WO2023200796A1/en not_active Ceased
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025513879A5 (https=) | ||
| JP2023126852A5 (https=) | ||
| FI3535392T3 (fi) | Immunologisesti havaittavia solupintavariantteja käytettäväksi soluterapiassa | |
| JP2019533450A5 (https=) | ||
| JP2024506682A5 (https=) | ||
| JP2023515199A5 (https=) | ||
| US20060003452A1 (en) | Vector packaging cell line | |
| HRP20200251T1 (hr) | Proizvodnja i korištenje vitro-sintetizirane ssrna za uvođenje u ćelije sisavaca za proizvodnju biološkog ili biokemijskog učinka | |
| IL295897A (en) | Materials and methods for modulating an immune response | |
| JP2023537534A5 (https=) | ||
| JP2004528806A5 (https=) | ||
| CN116829698A (zh) | 通过SIRP-α衔接体的先天免疫细胞沉默 | |
| JP2025517657A5 (https=) | ||
| CN119183385A (zh) | 免疫检查点接合子对免疫细胞的抑制 | |
| JP2025516377A (ja) | 多重特異性抗体を含む治療薬及び腫瘍治療におけるその使用 | |
| EP4582456A1 (en) | Strengthened receptor, and immune cell expressing strengthened receptor and use thereof | |
| US20240417755A1 (en) | Fusion polypeptides for genetic editing and methods of use thereof | |
| US20260009051A1 (en) | Compositions and methods for artificial protospacer adjacent motif (pam) generation | |
| KR20230107610A (ko) | 키메라 항원 수용체를 발현하는 유전적으로 조작된 세포와 관련된 방법 및 조성물 | |
| US20250032544A1 (en) | Sirpalpha switch receptors | |
| WO2024177982A2 (en) | Lilrb1 engager cells | |
| WO2024177978A1 (en) | Lilrb3 engager cells | |
| CN116744963A (zh) | 与表达嵌合抗原受体的经基因工程化的细胞有关的方法和组合物 | |
| HK40014655A (en) | Immunologically discernible cell surface variants for use in cell therapy | |
| HK40014655B (en) | Immunologically discernible cell surface variants for use in cell therapy |